本页面由Tiger Trade Technology Pte. Ltd.提供服务

Xenon制药

34.42
-1.3900-3.88%
盘后:34.460.0400+0.12%16:10 EDT
成交量:110.40万
成交额:3,839.18万
市值:33.26亿
市盈率:-7.31
高:35.90
开:35.65
低:34.38
收:35.81
52周最高:72.66
52周最低:34.38
股本:9,664.28万
流通股本:9,544.94万
量比:0.61
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-4.7061
每股收益(LYR):-4.3646
净资产收益率:-43.62%
总资产收益率:-28.02%
市净率:2.68
市盈率(LYR):-7.89

数据加载中...

2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/13

重要事件披露

Form 8-K - Current report
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

重要事件披露

Form 8-K - Current report
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/11

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report